Multiple sclerosis: Pathology, diagnosis and treatments

WJ Huang, WW Chen, X Zhang - Experimental and …, 2017 - spandidos-publications.com
Multiple sclerosis (MS) is a complex neurodegenerative disease affecting the central
nervous system (CNS). The onset of MS has been typically observed in individuals aged …

[HTML][HTML] Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS)

C Trebst, S Jarius, A Berthele, F Paul, S Schippling… - Journal of …, 2014 - Springer
Neuromyelitis optica (NMO, Devic's syndrome), long considered a clinical variant of multiple
sclerosis, is now regarded as a distinct disease entity. Major progress has been made in the …

Multiple sclerosis: current knowledge and future outlook

CP Kamm, BM Uitdehaag, CH Polman - European neurology, 2014 - karger.com
Background: Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous
system characterized by demyelination and axonal loss. The etiology of MS is unknown; …

[HTML][HTML] Cognitive dysfunctions and assessments in multiple sclerosis

C Oreja-Guevara, T Ayuso Blanco… - Frontiers in …, 2019 - frontiersin.org
Cognitive impairment has been reported at all phases and all subtypes of multiple sclerosis.
It remains a major cause of neurological disability in young and middle-aged adults suffering …

Sativex® as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled …

J Markovà, U Essner, B Akmaz, M Marinelli… - International Journal …, 2019 - Taylor & Francis
Purpose/aim: To evaluate the efficacy of tetrahydrocannabinol (THC): cannabidiol (CBD)
oromucosal spray (Sativex®) as add-on therapy to optimised standard antispasticity …

[HTML][HTML] Exercise in multiple sclerosis--an integral component of disease management

A Döring, CF Pfueller, F Paul, J Dörr - Epma journal, 2012 - Springer
Multiple sclerosis (MS) is the most common chronic inflammatory disorder of the central
nervous system (CNS) in young adults. The disease causes a wide range of symptoms …

Is Mediterranean diet associated with multiple sclerosis related symptoms and fatigue severity?

Y Ertaş Öztürk, EM Helvaci… - Nutritional …, 2023 - Taylor & Francis
Objective Nutrition modulation can reduce multiple sclerosis (MS) related symptoms and
fatigue severity. Mediterranean diet may be beneficial regarding anti-inflammatory …

[HTML][HTML] Present and future therapies in neuromyelitis optica spectrum disorders

I Kleiter, R Gold - Neurotherapeutics, 2016 - Elsevier
Neuromyelitis optica spectrum disorders (NMOSD) are important evolving entities, which
have reached much attention in the recent years. NMOSD are characterized by inflammatory …

How multiple sclerosis symptoms vary by age, sex, and race/ethnicity

I Kister, T Bacon, GR Cutter - Neurology: Clinical Practice, 2021 - AAN Enterprises
Objective Little is known about how symptom severity in the various neurologic domains
commonly affected by multiple sclerosis (MS) varies by age, sex, and race/ethnicity. Methods …

Neuropsychological, medical and rehabilitative management of persons with multiple sclerosis

J DeLuca, U Nocentini - NeuroRehabilitation, 2011 - content.iospress.com
Multiple sclerosis (MS) is a chronic and disabling disease that attacks the central nervous
system (CNS). The symptoms, progression, and severity of the disease are unpredictable …